Previous Close | 2.4500 |
Open | 2.4200 |
Bid | 2.1500 |
Ask | 2.9000 |
Strike | 3.50 |
Expire Date | 2025-01-17 |
Day's Range | 2.4500 - 2.4500 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Despite a revenue dip, Bionano Genomics Inc (BNGO) sees promising growth in its OGM installed base and strategic partnerships.
Special Meeting of Stockholders Adjourned Due to Lack of QuorumSAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it has adjourned its Special Meeting of Stockholders held on October 2, 2024 (the “Special Meeting”) because a quorum was not present at the time of meeting. Based on preliminary reports as of October 2, 2024, only 22.5% of total shares outstanding as of the record date have submitted their votes, whereas 33.3% of total shares outs
Bionano Genomics (BNGO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.